Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Duodopa 20 mg/ml + 5 mg/ml intestinal gel

Active Ingredient:
levodopa, carbidopa monohydrate
Company:  
AbbVie Ltd See contact details
ATC code: 
N04BA02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Duodopa Best practice patient aftercare

{healthcare_pro_orange} For Healthcare Professionals

This short guide provides advice to healthcare professionals on the management of patients with advanced Parkinson’s disease who have started Duodopa therapy

{pdf_link}

Duodopa Critical Aspects of PEG-J Preparation Placement and Aftercare

{healthcare_pro_orange} For Healthcare Professionals

The information presented in these slides is provided as part of additional Risk Minimisation Program for Duodopa targeted to minimise: –Gastrointestinal (GI) events –Device-related risks –Procedure-related risks associated with the levodopa – carbidopa intestinal gel (LCIG) system

{pdf_link}

Duodopa PEG-J aftercare guideline

{healthcare_pro_orange} For Healthcare Professionals

This guide provides advice to healthcare professionals on how to minimise PEG-J tube related complications in patients receiving Duodopa therapy. It should be used in conjunction with any local guidance and the CADD-Legacy 1400 pump instruction manual.

{pdf_link}

Duodopa Patient Pocket Guide

{healthcare_pro_orange} For Healthcare Professionals

This pocket guide provides a practical overview of the Duodopa system and potential complications related to the medication and its delivery system.

{pdf_link}

Duodopa Safety, PEG-J insertion and aftercare, LCIG System Use and Pump Operations

{healthcare_pro_orange} For Healthcare Professionals

Important Additional Risk Minimisation Information for Healthcare Professionals Training for AbbVie Duodopa Specialists on LCIG System, PEG-J Placement, Aftercare and Minimisation of Procedure Complications

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

AbbVie Ltd
Company image
Address
AbbVie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4UB, UK
WWW
www.abbviemedinfo.com
WWW
www.abbvie.co.uk
Telephone
+44 (0)1628 561 092
Medical Information e-mail
[email protected]
Out of Hours Telephone
+44 (0)1628 561 092